A new study in Nature Communications reports that a molecular pathway involving SIRT5 and SUCLG2 can slow the pace of ovarian aging. The work by Xu, Song, Shi and colleagues frames ovarian decline not only as a problem of energy loss, but as an interconnected mitochondrial and epigenetic failure mode that progressively disrupts cell identity and function.
At the center of the findings is SIRT5, a mitochondrial-associated deacylase known for removing succinyl and related modifications from proteins. The researchers show that SIRT5 targets SUCLG2, a key component of the mitochondrial enzyme complex that regulates succinate-related metabolism. By promoting SUCLG2 desuccinylation, the pathway helps preserve more stable mitochondrial metabolic flux.
The team links these biochemical effects to epigenetic regulation, arguing that mitochondrial metabolites feed directly into the cell’s chromatin state. In aging ovaries, metabolite imbalance can alter epigenetic marks, shifting gene expression programs toward dysfunction. In contrast, maintaining the SIRT5–SUCLG2 axis appears to reduce maladaptive epigenetic remodeling.
Mechanistically, the authors describe how improved mitochondrial function can limit pro-aging metabolic cues that would otherwise reshape chromatin landscapes. This produces downstream changes in gene networks essential for follicle maintenance and ovarian tissue resilience. The study therefore proposes a “mitochondrial–epigenetic regulatory mechanism” as a causal bridge between metabolism and aging-related transcriptional drift.
Importantly, the paper emphasizes that the desuccinylation event is not merely correlational. Manipulating components of the axis changes ovarian aging trajectories in experimental models, consistent with a functional role in regulating cellular stress responses and preserving ovarian microenvironments.
The findings also suggest that succinylation marks may act as a metabolic readout that tunes mitochondrial enzymes—and, by extension, epigenetic control systems. This creates a potential framework for understanding why mitochondrial aging signatures often precede or accompany epigenetic change.
For translational relevance, the work points to SIRT5 activity and SUCLG2 modification status as candidate targets for therapeutic strategies aimed at extending reproductive healthspan. Rather than focusing solely on downstream epigenetic enzymes, intervening at mitochondrial post-translational regulation could offer a more upstream handle.
Overall, the report positions the SIRT5–SUCLG2 desuccinylation axis as a modifiable regulator of ovarian aging. By connecting mitochondrial chemistry to chromatin behavior, the study provides a viral-style, systems-level explanation of how small protein modifications may drive long-range biological outcomes.
Subject of Research: Ovarian aging; mitochondrial metabolism; epigenetic regulation
Article Title: The SIRT5-SUCLG2 desuccinylation axis delays ovarian aging via a mitochondrial-epigenetic regulatory mechanism.
Article References: Xu, D., Song, S., Shi, Q. et al. The SIRT5-SUCLG2 desuccinylation axis delays ovarian aging via a mitochondrial-epigenetic regulatory mechanism. Nat Commun (2026). https://doi.org/10.1038/s41467-026-75502-x
Image Credits: AI Generated
DOI: 10.1038/s41467-026-75502-x
Keywords: SIRT5; SUCLG2; desuccinylation; mitochondrial–epigenetic regulation; ovarian aging
